1. Home
  2. ALKT vs NBTX Comparison

ALKT vs NBTX Comparison

Compare ALKT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkami Technology Inc.

ALKT

Alkami Technology Inc.

HOLD

Current Price

$18.79

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$39.62

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKT
NBTX
Founded
2007
2003
Country
United States
France
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
ALKT
NBTX
Price
$18.79
$39.62
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$28.57
$36.00
AVG Volume (30 Days)
2.1M
66.2K
Earning Date
04-29-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$152,159,000.00
N/A
Revenue This Year
$21.85
$58.17
Revenue Next Year
$16.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
35.68
N/A
52 Week Low
$13.98
$4.79
52 Week High
$30.88
$57.14

Technical Indicators

Market Signals
Indicator
ALKT
NBTX
Relative Strength Index (RSI) 69.59 57.25
Support Level $15.16 $38.89
Resistance Level $19.23 $41.89
Average True Range (ATR) 0.76 2.55
MACD 0.41 0.45
Stochastic Oscillator 91.35 96.34

Price Performance

Historical Comparison
ALKT
NBTX

About ALKT Alkami Technology Inc.

Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: